Dan Limbach
OK. So the iPad is cool. It is selling like hotcakes (or maybe IHOP and Denny's wished hotcakes sold like iPads). Is it a good platform for pharma? Here's a roundup of some of the better recent articles on the subject.
Otsuka Dives Into iPad
June 8 (Bloomberg) -- Otsuka Pharmaceutical Co. said it will buy 1,300 Apple Inc. iPads for its sales representatives in Japan to market the company’s medicines.
Read full article
John Mack ponders whether Pharma is embracing or resisting the iPad for sales reps.
Read full article
Motorola Inc, maker of the Droid smartphone, is planning to release a tablet computer based on Google Inc’s Android software to challenge Apple Inc’s iPad, according to two people familiar with the plan.
Dan here: The open nature of the Android OS makes it an attractive package for developing custom apps. While the iPad will always have an adge on the "hip" factor, an Andriod-based pad could become a major competitor to the iPad for business use.
Read full article
Otsuka Dives Into iPad
June 8 (Bloomberg) -- Otsuka Pharmaceutical Co. said it will buy 1,300 Apple Inc. iPads for its sales representatives in Japan to market the company’s medicines.
Read full article
John Mack ponders whether Pharma is embracing or resisting the iPad for sales reps.
Read full article
Motorola Inc, maker of the Droid smartphone, is planning to release a tablet computer based on Google Inc’s Android software to challenge Apple Inc’s iPad, according to two people familiar with the plan.
Dan here: The open nature of the Android OS makes it an attractive package for developing custom apps. While the iPad will always have an adge on the "hip" factor, an Andriod-based pad could become a major competitor to the iPad for business use.
Read full article
Posts
0 comments:
Post a Comment